We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+6.01%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$581M
AUM Growth
+$45.7M
Cap. Flow
+$58.1M
Cap. Flow %
10.01%
Top 10 Hldgs %
44.52%
Holding
652
New
86
Increased
170
Reduced
261
Closed
45

Sector Composition

Rank Sector Weight
1 Financials 15.75%
2 Consumer Discretionary 8.13%
3 Materials 7.77%
4 Communication Services 6.16%
5 Technology 5.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WM icon
326
Waste Management
WM
$95B
$65.8K 0.01%
762
-22,752
-97% -$1.85M
MET icon
327
MetLife
MET
$62.4B
$63.9K 0.01%
1,263
-421
-25% -$22.2K
DNN icon
328
Denison Mines
DNN
$2.43B
$61.7K 0.01%
112,224
VOD icon
329
CALL
Vodafone
VOD
$37.1B
$57K 0.01%
750
-2
-0.3% -$60
VOD icon
330
PUT
Vodafone
VOD
$37.1B
$57K 0.01%
750
RY icon
331
Royal Bank of Canada
RY
$287B
$56.9K 0.01%
695
QGEN icon
332
CALL
Qiagen
QGEN
$8.62B
$56.2K 0.01%
1,001
-211
-17% -$7.27K
ICPT
333
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$55.5K 0.01%
950
-4,127
-81% -$260K
OXY icon
334
Occidental Petroleum
OXY
$55.7B
$55.4K 0.01%
752
+69
+10% +$4.68K
ALL icon
335
Allstate
ALL
$70.6B
$54.7K 0.01%
522
+355
+213% +$35K
PLD icon
336
Prologis
PLD
$136B
$53.1K 0.01%
823
-10,022
-92% -$655K
ALXN
337
DELISTED
Alexion Pharmaceuticals
ALXN
$50.1K 0.01%
419
+137
+49% +$16.7K
GEN icon
338
Gen Digital
GEN
$16.5B
$49.2K 0.01%
1,753
+992
+130% +$29.7K
HSBC icon
339
CALL
HSBC
HSBC
$352B
$49K 0.01%
55
IBB icon
340
iShares Biotechnology ETF
IBB
$9.45B
$48.7K 0.01%
456
+90
+25% +$9.62K
GSK icon
341
CALL
GSK
GSK
$107B
$48.7K 0.01%
+848
New +$39.2K
GSK icon
342
PUT
GSK
GSK
$107B
$48.7K 0.01%
+5
New +$231
BKR icon
343
Baker Hughes
BKR
$58.3B
$48.5K 0.01%
1,531
ATI icon
344
ATI
ATI
$24.3B
$47K 0.01%
+1,949
New +$46.4K
GE icon
345
CALL
GE Aerospace
GE
$364B
$47K 0.01%
+104
New +$9.93K
UEC icon
346
Uranium Energy
UEC
$4.47B
$46.8K 0.01%
26,431
-19,056
-42% -$26.8K
AABA
347
DELISTED
Altaba Inc
AABA
$46.3K 0.01%
663
AYI icon
348
Acuity Brands
AYI
$9.99B
$45K 0.01%
256
-53
-17% -$8.82K
CNI icon
349
Canadian National Railway
CNI
$78.5B
$45K 0.01%
545
CHKP icon
350
Check Point Software Technologies
CHKP
$14.3B
$44.6K 0.01%
431
+226
+110% +$24.5K

Similar funds

Exane Derivatives's Q4 2017 Portfolio in Review

As of Q4 2017, Exane Derivatives held 652 positions worth $581M, up 8.5% from $535M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Exane Derivatives deployed $58.1M of net new capital in Q4 2017, opening 86 new positions and adding to 170 existing holdings. Its largest new stake was Stellantis: 502,571 shares worth $9.19M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Materials.

On the sell side, the largest reduction was UBS Group, an estimated $38.1M trimmed.

  • Exane Derivatives's largest Q4 2017 buy was Stellantis: 502,571 shares worth $9.19M.
  • Exane Derivatives added most to Alphabet (Google) Class C in Q4 2017, an estimated $20.7M increase.
  • Exane Derivatives's biggest Q4 2017 reduction was UBS Group, cutting an estimated $38.1M.
  • Exane Derivatives fully exited WIX.com in Q4 2017, selling an estimated $4.58M.
  • Exane Derivatives's ten largest holdings make up 45% of its $581M portfolio in Q4 2017.
  • Exane Derivatives opened 86 new positions and closed 45 in Q4 2017.
  • Exane Derivatives's portfolio value rose 8.5% quarter-over-quarter to $581M.

Based on Exane Derivatives's 13F filing for Q4 2017, filed 29 Jan 2018.